Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Over-Mutated Mitochondrial, Lysosomal and TFEB-Regulated Genes in Parkinson's Disease. | J Clin Med | 2022 | 35330074 | PubTator, text mining | PubMed |
| Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer. | Int J Mol Sci | 2022 | 35328633 | PubTator, text mining | PubMed |
| Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions. | Cancers (Basel) | 2022 | 35326655 | PubTator, text mining | PubMed |
| Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer. | Cancer Med | 2022 | 35322585 | PubTator, text mining | PubMed |
| Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group. | Curr Oncol Rep | 2022 | 35320498 | PubTator, text mining | PubMed |
| Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers. | JCO Precis Oncol | 2022 | 35319967 | PubTator, text mining | PubMed |
| Development of a dynamic network biomarkers method and its application for detecting the tipping point of prior disease development. | Comput Struct Biotechnol J | 2022 | 35317238 | PubTator, text mining | PubMed |
| AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations. | Environ Mol Mutagen | 2022 | 35315142 | PubTator, text mining | PubMed |
| Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a case report. | Rev Fac Cien Med Univ Nac Cordoba | 2022 | 35312250 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Sex differences in body composition affect total airway resistance during puberty. | BMC Pediatr | 2022 | 35300646 | PubTator, text mining | PubMed |
| Establishing analytical validity of BeadChip array genotype data by comparison to whole-genome sequence and standard benchmark datasets. | BMC Med Genomics | 2022 | 35287663 | PubTator, text mining | PubMed |
| Editorial: Genome Instability: Old Problem, New Solutions. | Front Cell Dev Biol | 2022 | 35281085 | PubTator, text mining | PubMed |
| Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases. | Bosn J Basic Med Sci | 2022 | 35276058 | PubTator, text mining | PubMed |
| Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy. | Clin Sci (Lond) | 2022 | 35274136 | PubTator, text mining | PubMed |
| Clinical and genomic features of Chinese lung cancer patients with germline mutations. | Nat Commun | 2022 | 35273153 | PubTator, text mining | PubMed |
The 2022 On-site Padua Days on Muscle and Mobility Medicine hosts the University of Florida Institute of Myology and the Wellstone Center, March 30 - April 3, 2022 at the University of Padua and Thermae of Euganean Hills, Padua, Italy: The collection of abstracts. | Eur J Transl Myol | 2022 | 35272451 | PubTator, text mining | PubMed |
| Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology. | Cells | 2022 | 35269445 | PubTator, text mining | PubMed |
| Lynch-like Syndrome: Potential Mechanisms and Management. | Cancers (Basel) | 2022 | 35267422 | PubTator, text mining | PubMed |
| "It was a no-brainer": A qualitative study of factors driving previvors' decision-making when considering risk-reducing salpingectomy with delayed oophorectomy. | Gynecol Oncol Rep | 2022 | 35265744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=49